Melanoma Expressed-CD70 Is Regulated by RhoA and MAPK Pathways without Affecting Vemurafenib Treatment Activity

• Christine Pich ,

  Contributed equally to this work with: Christine Pich, Iotefa Teiti

  Current address: University of Lausanne, CIG, Lausanne CH-1015, Switzerland

  Affiliations INSERM UMR 1037, CRCT, Toulouse FR-31037, France, Université Paul Sabatier, Toulouse FR-31062, France

  ⨯
• Iotefa Teiti ,

  Contributed equally to this work with: Christine Pich, Iotefa Teiti

  Affiliations INSERM UMR 1037, CRCT, Toulouse FR-31037, France, Université Paul Sabatier, Toulouse FR-31062, France

  ⨯
• Guillaume Sarrabayrouse,

  Current address: Digestive System Research Unit, University Hospital Vall d’Hebron, Passeig Vall d’Hebron 119–129, Barcelona E08035, Spain

  Affiliations INSERM UMR 1037, CRCT, Toulouse FR-31037, France, Université Paul Sabatier, Toulouse FR-31062, France

  ⨯
• Franck Gallardo,

  Affiliation NeoVirTech, Institut des Sciences du vivant, Toulouse FR-31106, France

  ⨯
• Rémi Gence,

  Affiliations INSERM UMR 1037, CRCT, Toulouse FR-31037, France, Université Paul Sabatier, Toulouse FR-31062, France

  ⨯
• Anne-Françoise Tilkin-Mariamé

  * E-mail: anne-francoise.tilkin@inserm.fr

  Affiliations Université Paul Sabatier, Toulouse FR-31062, France, INSERM U1220, IRSD, Toulouse FR-31024, France

  ⨯